"We Identify, Quantify and Communicate Value through each Phase of the Product Lifecycle"
PAOR combines strategic vision with deep technical expertise, while having an intuitive understanding of the relevance and potential impact of various tactics.
Our mission is to provide real world health outcomes consulting at every phase of the product life cycle: from first in human to post launch support.
Every molecule or product has a unique value proposition and our strength is in identifying, quantifying and communicating this value to internal and external audiences.
We do this by combining deep technical knowledge with a strategic vision that lets us identify only the most compelling strategies and tactics.
PAOR is led by Deepa Lalla, B.Pharm, PhD. Deepa was most recently Associate Director at Genentech leading the Health Economic strategy for Herceptin, Kadcyla and Perjeta which have combined global sales of over $ 5 billion dollars. Deepa has over ten years of pharmaceutical industry experience in health economics and outcomes research and has supported multiple product and indication launches.
Our mission is to provide real world health outcomes consulting at every phase of the product life cycle: from first in human to post launch support.
Every molecule or product has a unique value proposition and our strength is in identifying, quantifying and communicating this value to internal and external audiences.
We do this by combining deep technical knowledge with a strategic vision that lets us identify only the most compelling strategies and tactics.
PAOR is led by Deepa Lalla, B.Pharm, PhD. Deepa was most recently Associate Director at Genentech leading the Health Economic strategy for Herceptin, Kadcyla and Perjeta which have combined global sales of over $ 5 billion dollars. Deepa has over ten years of pharmaceutical industry experience in health economics and outcomes research and has supported multiple product and indication launches.